Biomed Central Ltd

SHERPA: Unknown

People

  1. Budhu
    Budhu
  2. Cheung
    Cheung
  3. Liu
    Liu
  4. Zhong
    Zhong
  5. De Stanchina
    De Stanchina
  6. Deng
    Deng
  7. Guo
    Guo
  8. Hadjantonakis
    Hadjantonakis
  9. Hirschhorn Cymerman
    Hirschhorn Cymerman
  10. Nowotschin
    Nowotschin

Groups

  1. Sloan Kettering Institute Postdocs (193)
  2. GSK Faculty (115)
  3. Department of Medicine (89)
  4. Solid Tumor Oncology Division (75)
  5. Melanoma and Immunotherapeutics Service (51)
  6. Sloan Kettering Institute Faculty (49)
  7. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (37)
  8. Epidemiology and Biostatistics (37)
  9. Tow Center for Developmental Oncology (TCDO) (35)
  10. Center for Molecular Imaging and Biotechnology (32)
Search Within
  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (116)
  2. Meeting Abstract (63)
  3. Review (9)
  4. Research Letter (2)
  5. Conference Paper (1)
  6. Editorial (1)
  7. Guidelines (1)
Groups
  1. Sloan Kettering Institute Postdocs (193)
  2. GSK Faculty (115)
  3. Department of Medicine (89)
  4. Solid Tumor Oncology Division (75)
  5. Melanoma and Immunotherapeutics Service (51)
  6. Sloan Kettering Institute Faculty (49)

More Groups

People
  1. Taha Merghoub (45)
  2. Jedd Wolchok (43)
  3. Roberta Zappasodi (24)
  4. Sadna Budhu (22)
  5. Levi Mark Mangarin (11)
  6. Cailian Liu (10)

More People

Years
  1. 2025 (6)
  2. 2024 (11)
  3. 2023 (12)
  4. 2022 (27)
  5. 2021 (20)
  6. 2020 (22)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (86)
  2. Breast Cancer Research (12)
  3. BMC Bioinformatics (11)
  4. Genome Medicine (10)
  5. Journal of Hematology & Oncology (10)
  6. Genome Biology (9)

More Publications

Results (193)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection
    Journal Article

    Eroglu, Z.; Broman, K. K.; Thompson, J. F.; Nijhuis, A.; Hieken, T. J.; Kottschade, L.; Farma, J. M.; Hotz, M.; Deneve, J.; Fleming, M.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity
    Journal Article

    Bernard, P. L.; Delconte, R.; Pastor, S.; Laletin, V.; Costa Da Silva, C.; Goubard, A.; Josselin, E.; Castellano, R.; Krug, A.; Vernerey, J.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer
    Journal Article

    ten Hoorn, S.; Waasdorp, C.; van Oijen, M. G. H.; Damhofer, H.; Trinh, A.; Zhao, L.; Smits, L. J. H.; Bootsma, S.; van Pelt, G. W.; Mesker, W. E.; more...
    BMC Cancer (2022)

    Fulltext@MSK | Save
  • Navigating a newly diagnosed cancer through clinician-facilitated discussions of health-related patient values: A qualitative analysis
    Journal Article

    Lynch, K. A.; Bernal, C.; Romano, D. R.; Shin, P.; Nelson, J. E.; Okpako, M.; Anderson, K.; Cruz, E.; Desai, A. V.; Klimek, V. M.; more...
    BMC Palliative Care (2022)

    Fulltext@MSK | Save
  • Platelets subvert antitumor efficacy of T cell-recruiting bispecific antibodies
    Journal Article

    Lutz, M. S.; Klimovich, B.; Maurer, S.; Heitmann, J. S.; Märklin, M.; Zekri, L.; Jung, G.; Salih, H. R.; Hinterleitner, C.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Overcoming tumor heterogeneity by ex vivo arming of T cells using multiple bispecific antibodies
    Journal Article

    Park, J. A.; Cheung, N. V.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • High quality neoantigens are immunoedited in long-term pancreatic cancer survivors
    Meeting Abstract

    Sethna, Z.; Luksza, M.; Rojas, L.; Soares, K.; Leung, J.; Lihm, J.; Hoyos, D.; Dobrin, A.; Kappagantula, R.; Makohon-Moore, A.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • MHC-I skewing in mutant calreticulin-positive myeloproliferative neoplasms is countered by heteroclitic peptide cancer vaccination
    Meeting Abstract

    Gigoux, M.; Zappasodi, R.; Park, J.; Bozkus, C. C.; Mangarin, L.; Redmond, D.; Verma, S.; Schad, S.; George, M.; Venkatesh, D.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Combining a novel dual RAF/MEK inhibitor with immunomodulation to promote an anti-tumor response
    Meeting Abstract

    Dong, L.; Choi, H.; Budhu, S.; Schulze, I.; Mehanna, N.; Rosen, N.; Merghoub, T.; Wolchok, J.
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Pharmacologic modulation of tumor glycolysis to improve responses to immune checkpoint blockade therapy
    Meeting Abstract

    Verma, S.; Maniyar, R.; Ko, M.; Budhu, S.; Serganova, I.; Zappasodi, R.; Blasberg, R.; Merghoub, T.; Wolchok, J.; Mangarin, L.
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save